Tag: prostate cancer
UK National Screening Committee Defends Stance Against Routine Prostate Cancer Screening
UK's National Screening Committee publishes detailed position statements defending evidence-based approach to prostate cancer screening decisions. New guidance addresses multicancer…
NHS England Expands Precision Radiotherapy Access to Reduce Prostate Cancer Treatment Sessions from 20 to 5
NHS England announces expansion of precision radiotherapy (SABR) for prostate cancer patients, reducing treatment sessions from 20 to 5 while…
Ceramide Metabolism May Explain Racial Disparities in Prostate Cancer Drug Response
New research reveals that differences in ceramide lipid metabolism between Black and white men may explain racial disparities in prostate…
UK Restricts Prostate Cancer Screening to High-Risk Men Only
UK health advisors restrict prostate cancer screening to men with dangerous genetic variants and family cancer histories. The targeted approach…
Prostate Cancer Affects One in Eight Men: Early Symptoms and Detection Guidelines
New data reveals one in eight men will develop prostate cancer, yet early symptoms often go unrecognized. Understanding warning signs…
Triple-Drug Therapy Extends Survival in Advanced Prostate Cancer Trial
Triple-drug combination therapy significantly improved survival outcomes in advanced prostate cancer trial. The approach combines PARP inhibition with androgen-signaling blockers…
Perioperative Treatment Revolution Could Transform Prostate Cancer Outcomes
New evidence suggests perioperative therapy could fundamentally transform prostate cancer treatment outcomes. The approach challenges traditional sequencing of surgery and…
UK Expands Prostate Cancer Screening Trial to Include More Black Men at Higher Risk
NHS England expands its Transform prostate cancer screening trial to better include black men, who face twice the risk of…